Patient-Centered Oncology Care 2020

Managing the constantly evolving selection of therapies in oncology can be difficult, but is of the utmost importance to get the right treatment to the right patient, agreed a panel at Patient-Centered Oncology Care® 2020.

According to the final panel at Patient-Centered Oncology Care®, clinical pathways can create a new problem: if each payer tries to impose its own pathways, it’s an administrative and ethical nightmare.

The keynote address at Patient-Centered Oncology Care® 2020 focused on the way practices have benefitted from the Oncology Care Model as the pandemic wears on.

Panelists at Patient-Centered Oncology Care® 2020 discussed practical methods and the potential benefits of utilizing chronic care management (CCM) billing and telehealth in oncology.

Pharmacy benefit managers (PBMs), once just administrators created to ease claims processing, have grown to a position of power that comes with conflicts of interest aplenty, said a panel at Patient-Centered Oncology Care® 2020.

Harlan Levine, MD, highlighted the chasm present in oncology today during his talk during this year’s Patient-Centered Oncology Care® 2020 conference.

A panel at Patient-Centered Oncology Care® 2020 discussed the challenges of a pandemic as oncology practice transformation initiatives continue on.

As novel therapies drive up the cost of cancer care, federal policy decisions are being made that influence oncologists' ability to deliver cancer care, said Debra Patt, MD, PhD, MBA, MPH, of Texas Oncology.

Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.